.Amgen has actually discussed (PDF) the 1st phase 3 records on its $400 thousand chronic eczema drug...
.Biogen and also UCB's bank on developing into stage 3 on the back of a broken research aims to have...
.Italian biotech Aptadir Rehabs has introduced with the guarantee that its own pipe of preclinical R...
.Surge Life Sciences has actually met its target in a Duchenne muscle dystrophy (DMD) research, inst...
.After a couple of years in biotech, Mike Quigley, Ph.D., is returning to the pharma fold, occupying...
.Achilles Therapeutics has wrecked its tactic. The English biotech is stopping work on its clinical-...
.Aligos Therapeutics is actually declaring a midstage succeed in metabolic-dysfunction affiliated st...
.Basilea Pharmaceutica's work establishing brand-new antifungals has gotten a significant boost comi...
.Possessing already gathered up the united state rights to Capricor Rehabs' late-stage Duchenne musc...
.After pushing the selection date for Applied Therapeutics' metabolic problem medication govorestat,...